20121111
 Corporate News: Merck's New Type of Cancer Drug Shows Promise   By Winslow, Ron, The Wall Street Journal,  Nov 12, 2012  Merck & Co. said Sunday an experimental cancer drug showed promise in an early-stage trial of skin-cancer patients, staking the company's ground in an emerging race to develop medicines that unleash the immune system's power to fight malignancies.   
